Fig. 1 · Structure

Documents & Downloads

Amprenavir

Cat. No. A11985 CAS 161814-49-9
Amprenavir is an human immunodeficiency virus (HIV) protease inhibitor with IC50 of 14.6 ± 12.5 ng/ml for wild-type HIV isolates

In Stock

Publications for Amprenavir

1 publication citing this product

  1. Reiko Watanabe, .et al. , J Med Chem, 2021, Mar 11;64(5):2725-2738 PMID: 33619967

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
PXR N/A
HIV protease 14.6 ng/mL

Cellular Effect

Cell Line Activity Value Description Reference
C8166 CC50 0.23 mM Cytostatic activity against human C8166 cells by MTT assay [PMID: 22306123]
C8166 EC50 2.93 nM Antiviral activity against HIV1 3B infected in human C8166 cells assessed as inhibition of syncytia formation after 3 days [PMID: 22306123]
CCRF-CEM EC50 404 nM Antiviral activity against HIV2 ROD with protease G17N/V47A mutation infected in human CEM cells assessed as inhibition of virus production after 7 days by Lenti-RT activity assay [PMID: 17576848]
CCRF-CEM EC50 583 nM Antiviral activity against HIV2 ROD with protease G17N mutation infected in human CEM cells assessed as inhibition of virus production after 7 days by Lenti-RT activity assay [PMID: 17576848]
CCRF-CEM EC50 630 nM Antiviral activity against HIV2 ROD with protease V47A mutation infected in human CEM cells assessed as inhibition of virus production after 7 days by Lenti-RT activity assay [PMID: 17576848]
CCRF-CEM EC50 855 nM Antiviral activity against wild type HIV2 ROD infected in human CEM cells assessed as inhibition of virus production after 7 days by Lenti-RT activity assay [PMID: 17576848]
HEK293 EC50 1.8 nM Antiviral activity against wild type HIV1 clade B isolated form HIV1 patient infected in HEK293 cells assessed as reduction in viral replication incubated for 48 hrs by luciferase reporter based assay [PMID: 22708897]
HEK293 EC50 10.7 nM Antiviral activity against wild type HIV1 NL4-3 in HEK293 cells after 48 hrs by replication-deffective luciferase reporter gene-based phenotypic assay [PMID: 17638694]
HEK293 EC50 15.6 nM Antiviral activity against multidrug resistant HIV1 MDR1 containing protease M46I, I54V, V82A and L90M mutant infected in HEK293 cells assessed as reduction in viral replication incubated for 48 hrs by luciferase reporter based assay [PMID: 22708897]
HEK293 EC50 17.5 nM Antiviral activity against multidrug resistant HIV1 MDRC4 infected in HEK293 cells assessed as reduction in viral replication incubated for 48 hrs by luciferase reporter based assay [PMID: 22708897]
HEK293 EC50 2.6 nM Antiviral activity against wild type HIV1 clade A isolated form HIV1 patient infected in HEK293 cells assessed as reduction in viral replication incubated for 48 hrs by luciferase reporter based assay [PMID: 22708897]
HEK293 EC50 3 nM Antiviral activity against wild type HIV1 infected in HEK293 cells assessed as reduction in viral replication incubated for 48 hrs by luciferase reporter based assay [PMID: 22708897]
HEK293 EC50 3.7 nM Antiviral activity against wild type HIV1 clade C isolated form HIV1 patient infected in HEK293 cells assessed as reduction in viral replication incubated for 48 hrs by luciferase reporter based assay [PMID: 22708897]
HepG2 CC50 98.4 μM Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 5 days by XTT assay 10.1039/C1MD00147G
MT2 CC50 > 100 μM Cytotoxicity against human MT2 cells after 7 days by MTT assay [PMID: 20439612]
MT2 CC50 > 100 μM Cytotoxicity against human MT2 cells by MTT assay [PMID: 18955518]
MT2 CC50 > 100 μM Cytotoxicity against human MT2 cells assessed as inhibition of p24 Gag protein expression by MTT assay [PMID: 17371811]
MT2 CC50 > 100 μM Cytotoxicity against human MT2 cells assessed as reduction in cell viability after 5 days by XTT assay 10.1039/C1MD00147G
MT2 EC50 0.024 μM Antiviral activity against HIV1 LAI infected in human MT2 cells by MTT assay [PMID: 20439612]

19 records · Scroll to view more

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 161814-49-9
Formula C25H35N3O6S
Molecular Weight 505.63
SMILES
CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 15 mg/mL (29.66 mM)
Water Insoluble
Ethanol 91 mg/mL (179.97 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Publications

1 publication citing this product

  1. Reiko Watanabe, .et al. , J Med Chem, 2021, Mar 11;64(5):2725-2738 PMID: 33619967

Added to your cart

View Cart Checkout
Loading...